ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,919Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 298

$553K Total Retail Price of All Prescriptions

Rank: 20 out of 298

396 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 645 570 1 1
LISINOPRIL 476 441 2 4
AMLODIPINE BESYLATE 450 444 3 6
POTASSIUM CHLORIDE 417 382 4 11
SIMVASTATIN 405 386 5 2
LOSARTAN POTASSIUM 352 306 6 18
OMEPRAZOLE 342 268 7 3
FUROSEMIDE 318 295 8 5
METFORMIN HCL 246 215 9 10
WARFARIN SODIUM 242 242 10 7
ATENOLOL 235 214 11 16
HYDROCHLOROTHIAZIDE 203 193 12 13
GABAPENTIN 200 184 13 20
SERTRALINE HCL 195 159 14 19
METOPROLOL TARTRATE 184 179 15 9
ATORVASTATIN CALCIUM 172 166 16 14
TRAMADOL HCL 168 157 17 15
TRIAMTERENE-HCTZ 150 144 18 43
HYDROCODONE-ACETAMINOPHEN 145 131 S3 19 8
PRAVASTATIN SODIUM 128 125 20 31
LOSARTAN-HYDROCHLOROTHIAZIDE 126 126 21 44
MELOXICAM 124 107 22 41
ALENDRONATE SODIUM 123 123 23 21
ZOLPIDEM TARTRATE 110 107 24 25
TRAZODONE HCL 108 105 25 39
CITALOPRAM HBR 103 103 26 17
ALLOPURINOL 102 98 27 28
FLUTICASONE PROPIONATE 99 76 28 38
CRESTOR 95 95 29 26
METOPROLOL SUCCINATE 93 67 30 12
CARVEDILOL 91 91 31 23
SYNTHROID 91 86 31 42
QUETIAPINE FUMARATE 88 87 33 68
CLONIDINE HCL 87 84 34 82
FENOFIBRATE 82 75 35 62
BYSTOLIC 81 71 36 127
DONEPEZIL HCL 75 75 37 22
ISOSORBIDE MONONITRATE ER 73 73 38 45
FENTANYL 70 49 S2 39 32
OXYBUTYNIN CHLORIDE 69 69 40 81
NEXIUM 68 58 41 40
SPIRONOLACTONE 66 59 42 34
MIRTAZAPINE 64 64 43 37
CYMBALTA 62 55 44 67
DIGOXIN 62 62 44 27
DILTIAZEM 24HR CD 61 61 46 74
AZITHROMYCIN 61 55 46 63
OXYCODONE HCL 58 58 S2 48 79
VOLTAREN 57 57 49 225
FLUOXETINE HCL 56 45 50 50
NAMENDA 54 54 51 35
TAMSULOSIN HCL 53 50 52 24
GLIPIZIDE 53 50 52 69
CLOPIDOGREL 52 52 54 36
ESTRADIOL 51 40 R 55 239
CIPROFLOXACIN HCL 50 49 56 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.